secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2026-06-25T12:30:49+00:00
Accession:  0001104659-26-077556
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS amends CEO Stergiou's COC severance to lump sum; revises Burns, Cicic agreements
--------------------------------------------------------------------------------

- CEO Stergiou's change-in-control severance: lump sum of 24 months base salary plus 1.5x target bonus, full equity vesting, 18-month COBRA.
- Non-COC severance for CFO Burns and SVP Cicic: 9 months base salary, pro-rata target bonus, up to 9 months COBRA reimbursement.
- COC severance for Burns and Cicic: lump sum of 15 months base salary plus target bonus, 18-month COBRA, immediate full equity vesting.
- All three agreements were approved by the board on June 24, 2026, after compensation committee review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465926077556/0001104659-26-077556-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465926077556/tm2618927d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-077556

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer